Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Hist Cienc Saude Manguinhos ; 22 Suppl: 1749-63, 2015 Dec.
Artigo em Português | MEDLINE | ID: mdl-26785877

RESUMO

Museu da Saúde (Museum of Health) in Portugal, based on the dual concept of a multifaceted physical space and a virtual space, is preparing an inventory of its archive. So far, it has studied five of its collections in greater depth: tuberculosis, urology, psychology, medicine, and malaria. In this article, these collections are presented, and the specificities of developing museological activities within a national laboratory, Instituto Nacional de Saúde Doutor Ricardo Jorge, are also discussed, highlighting the issues of the store rooms and exhibition spaces, the inventory process, and the communication activities, with a view to overcoming the challenges inherent to operating in a non-museological space.


Assuntos
Saúde , Medicina , Museus , Arquivos , Arquitetura de Instituições de Saúde , Educação em Saúde , Portugal
2.
J Clin Virol ; 57(1): 5-12, 2013 05.
Artigo em Inglês | MEDLINE | ID: mdl-23375738

RESUMO

Two classes of antiviral drugs are licensed in Europe for treatment and prophylaxis of influenza; the M2 ion-channel blockers amantadine and rimantadine acting against type A influenza viruses only and the neuraminidase enzyme inhibitors zanamivir and oseltamivir acting against type A and type B influenza viruses. This guidance document was developed for but not limited to the European Union (EU) and other European Economic Area (EEA) countries on how and when to test for influenza virus antiviral drug susceptibility. It is aimed at clinical and influenza surveillance laboratories carrying out antiviral drug susceptibility testing on influenza viruses from patients suspected of harbouring viruses with reduced susceptibility or for the monitoring of the emergence of such among circulating viruses, respectively. Therefore, the guidance should not be read as a directive or an algorithm for treatment. Monitoring for emergence of influenza viruses with reduced drug susceptibility in hospitalized cases is crucial for decision making on possible changes to antiviral treatment. Therefore, it is important to test for antiviral susceptibility in certain patient groups, such as patients treated with influenza antiviral drugs. It is also important to determine the frequency of viruses with natural (not related to drug use) reduced susceptibility among community and hospitalized cases, as this knowledge is essential for making empirical antiviral treatment decisions. Furthermore, testing of specimens from community influenza patients is needed to determine the frequency of viruses with reduced susceptibility and good viral fitness that are readily transmissible, as they may become dominant among circulating viruses. Phenotypic neuraminidase enzyme inhibition assays are recommended to determine the level of inhibition of the neuraminidase enzyme by antiviral drugs as a measure of drug susceptibility of the virus. Genotypic assays are recommended to identify amino acid substitutions in the neuraminidase and M2 ion-channel proteins that have been associated with reduced antiviral susceptibility previously. By 2012 all circulating seasonal influenza A(H1N1)pdm09 and A(H3N2) viruses were naturally resistant to the M2 ion-channel blockers, so priority should be given to testing for neuraminidase inhibitor susceptibility.


Assuntos
Antivirais/farmacologia , Orthomyxoviridae/efeitos dos fármacos , Virologia/métodos , Virologia/normas , Farmacorresistência Viral , Humanos , Vírus da Influenza A Subtipo H1N1/efeitos dos fármacos , Vírus da Influenza A Subtipo H1N1/isolamento & purificação , Vírus da Influenza A Subtipo H3N2/efeitos dos fármacos , Vírus da Influenza A Subtipo H3N2/isolamento & purificação , Influenza Humana/virologia , Testes de Sensibilidade Microbiana , Orthomyxoviridae/isolamento & purificação , Garantia da Qualidade dos Cuidados de Saúde
3.
Hist. ciênc. saúde-Manguinhos ; 22(supl): 1749-1763, oct.-dic. 2015. graf
Artigo em Português | LILACS | ID: lil-769734

RESUMO

Resumo O Museu da Saúde em Portugal, baseado no duplo conceito de espaço físico polinucleado e espaço virtual, desenvolve o inventário do seu acervo, tendo, até ao momento, estudado mais aprofundadamente cinco das suas coleções – Tuberculose, Urologia, Psicologia, Medicamento e Malária. Neste artigo, o museu apresenta essas coleções, bem como a problemática do desenvolvimento da atividade museológica no espaço de um laboratório nacional, o Instituto Nacional de Saúde Doutor Ricardo Jorge, salientando as questões dos espaços de reserva e de exposição, o processo de inventário e as atividades de divulgação, atendendo aos desafios inerentes a uma atividade desenvolvida num espaço não museológico.


Abstract Museu da Saúde (Museum of Health) in Portugal, based on the dual concept of a multifaceted physical space and a virtual space, is preparing an inventory of its archive. So far, it has studied five of its collections in greater depth: tuberculosis, urology, psychology, medicine, and malaria. In this article, these collections are presented, and the specificities of developing museological activities within a national laboratory, Instituto Nacional de Saúde Doutor Ricardo Jorge, are also discussed, highlighting the issues of the store rooms and exhibition spaces, the inventory process, and the communication activities, with a view to overcoming the challenges inherent to operating in a non-museological space.


Assuntos
Saúde , Medicina , Museus , Arquivos , Arquitetura de Instituições de Saúde , Educação em Saúde , Portugal
7.
Rev. Inst. Med. Trop. Säo Paulo ; 41(1): 13-20, Jan.-Feb. 1999. ilus, tab
Artigo em Inglês | LILACS | ID: lil-236720

RESUMO

For the purpose of research a large quantity of anti-measles IgG working reference serum was needed. A pool of sera from five teenagers was prepared and named Alexandre Herculano (AH). In order to calibrate the AH serum, 18 EIA assays were performed testing in parallel AH and the 2nd International Standard 1990, Anti-Measles Antibody, 66/202 (IS) in a range of dilutions (from 1/50 to 1/25600). A method which compared parallel lines resulting from the graphic representation of the results of laboratory tests was used to estimate the power of AH relative to IS. A computer programme written by one of the authors was used to analyze the data and make potency estimates. Another method of analysis was used, comparing logistic curves relating serum concentrations with optical density by EIA. For that purpose an existing computer programme (WRANL) was used. The potency of AH relative to IS, by either method, was estimated to be 2.4. As IS has 5000 milli international units (mIU) of anti-measles IgG per millilitre (ml), we concluded that AH has 12000 mIU/ml.


Assuntos
Humanos , Adolescente , Calibragem , Vacina contra Sarampo/imunologia , Padrões de Referência , Técnicas Imunoenzimáticas , Imunoglobulina G/imunologia , Sarampo/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA